Revance Therapeutics Market Cap

Vastned has a market cap or net worth of €478.08 million as of August 8, 2025. Its market cap has increased by 214.84% in one year.

Market Cap

478.08M

Enterprise Value

985.14M

Revenue

42.87M

Ranking

n/a

PE Ratio

11.16

Stock Price

$29.60

Market Cap Chart

Since January 24, 2007, Vastned's market cap has increased from 203.29M to 478.08M, an increase of 135.17%. That is a compound annual growth rate of 4.72%.

Market Cap History

Date	Market Cap	% Change
Aug 8, 2025	478.08M	241.08%
Dec 31, 2024	140.17M	-10.39%
Dec 29, 2023	156.42M	3.70%
Dec 30, 2022	150.83M	3.13%
Dec 31, 2021	146.26M	20.00%
Dec 31, 2020	121.88M	-46.31%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Warehouses De Pauw	4.97B
Shurgard Self Storage	3.53B
Aedifica NV/SA	3.12B
Cofinimmo	2.94B
VGP NV	2.54B
Montea Comm. VA	1.53B
Xior Student Housing NV	1.48B
Retail Estates	1.00B

Market Cap Rankings